JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.02B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.02B |
| 3 |
Truist Financial
TFC
|
+$1B |
| 4 |
Tesla
TSLA
|
+$912M |
| 5 |
Johnson & Johnson
JNJ
|
+$842M |
Top Sells
| 1 |
Pfizer
PFE
|
+$1.5B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.27B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| 1 | Technology | 14.23% |
| 2 | Financials | 13.12% |
| 3 | Healthcare | 10.39% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Industrials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
IMAX
IMAX
$1.74B
| $1.92M | ﹤0.01% |
93,874
+20,370
| +28% | +$416K |
|
|
IMGN
2577
DELISTED
Immunogen Inc
IMGN
| $1.92M | ﹤0.01% |
375,454
+296,201
| +374% | +$1.51M |
|
|
OXFD
2578
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.92M | ﹤0.01% |
115,353
+656
| +0.6% | +$10.9K |
|
2579
SPDR S&P Semiconductor ETF
XSD
$1.52B
| $1.91M | ﹤0.01% |
18,068
+506
| +3% | +$53.6K |
|
2580
Vanguard Mega Cap Growth ETF
MGK
$30.3B
| $1.91M | ﹤0.01% |
13,122
-22
| -0.2% | -$3.2K |
|
|
CEO
2581
DELISTED
CNOOC Limited
CEO
| $1.9M | ﹤0.01% |
11,416
-16,803
| -60% | -$2.8M |
|
2582
Piper Sandler
PIPR
$6.27B
| $1.9M | ﹤0.01% |
23,807
-18,091
| -43% | -$1.45M |
|
2583
Vanguard Mid-Cap Growth ETF
VOT
$17.8B
| $1.9M | ﹤0.01% |
11,951
+4,865
| +69% | +$772K |
|
2584
Matsons
MATX
$3.37B
| $1.89M | ﹤0.01% |
46,353
-7,292
| -14% | -$298K |
|
|
LGF.B
2585
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.89M | ﹤0.01% |
190,552
-75,866
| -28% | -$753K |
|
2586
VEON
VEON
$3.61B
| $1.89M | ﹤0.01% |
29,797
-38,987
| -57% | -$2.47M |
|
2587
Spok Holdings
SPOK
$360M
| $1.88M | ﹤0.01% |
153,575
-17,710
| -10% | -$217K |
|
2588
Seres Therapeutics
MCRB
$154M
| $1.87M | ﹤0.01% |
27,094
-2,498
| -8% | -$172K |
|
2589
SPDR MSCI USA Gender Diversity ETF
SHE
$274M
| $1.86M | ﹤0.01% |
24,094
-2,218
| -8% | -$171K |
|
2590
SPDR S&P Regional Banking ETF
KRE
$3.88B
| $1.86M | ﹤0.01% |
31,932
-5,162,760
| -99% | -$301M |
|
2591
Aquestive Therapeutics
AQST
$584M
| $1.85M | ﹤0.01% |
318,581
+206,778
| +185% | +$1.2M |
|
|
HALL
2592
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.85M | ﹤0.01% |
10,548
-1,595
| -13% | -$280K |
|
2593
Sabesp
SBS
$16.4B
| $1.85M | ﹤0.01% |
122,894
-346,530
| -74% | -$5.21M |
|
|
WSR
2594
Whitestone REIT
WSR
$649M
| $1.85M | ﹤0.01% |
135,672
-33,898
| -20% | -$462K |
|
|
UCFC
2595
DELISTED
United Community Financial Corp
UCFC
| $1.85M | ﹤0.01% |
158,390
-99,421
| -39% | -$1.16M |
|
2596
Intellia Therapeutics
NTLA
$1.33B
| $1.85M | ﹤0.01% |
125,815
+113,140
| +893% | +$1.66M |
|
2597
Zurn Elkay Water Solutions
ZWS
$7.91B
| $1.85M | ﹤0.01% |
117,412
+7,843
| +7% | +$123K |
|
2598
First Trust Health Care AlphaDEX Fund
FXH
$916M
| $1.84M | ﹤0.01% |
21,808
-2,528
| -10% | -$213K |
|
2599
Allient
ALNT
$777M
| $1.82M | ﹤0.01% |
56,399
+10,655
| +23% | +$344K |
|
2600
JPMorgan BetaBuilders US Equity ETF
BBUS
$5.49B
| $1.82M | ﹤0.01% |
31,427
| – | – |
|